Development of an MRI phantom for diffusion‐weighted imaging with independent adjustment of apparent diffusion coefficient values and T2 relaxation times

Abstract

To design a phantom for diffusion-weighted imaging (DWI) with defined apparent diffusion coefficients (ADC) and T2 relaxation times. Varying concentrations of polyethylene glycol (PEG) were used for the adjustment of diffusivity. T2 relaxation times were tuned by adding of the MR contrast agent gadobutrol. Relaxation times and apparent diffusion coefficients were quantified using a multiecho spin echo sequence and an echo planar imaging (EPI) DWI sequence, respectively, on a 3T clinical scanner. Increasing concentrations of PEG led to a marked impairment of diffusivity accompanied by only moderate changes of T2 relaxation times. Adding gadobutrol to the PEG solutions allowed for adjustment of transverse relaxation times to predefined values. Thus, a broad range of defined ADC values and T2 relaxation times could be accurately achieved in the final phantom. The proposed phantom allows for standardized in vitro studies of DWI methods and protocols. The obtained MR image contrasts are similar to a variety of biological tissues, which can contribute to optimization of imaging techniques with respect to specific clinical questions. Due to the simplicity of design and the accessibility of the contained compounds, this phantom may also serve as a tool for standardization and calibration.